• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
sketching charcoal filling in filling out fill in fill out sketch
Pharma

BMS is augmenting Zenbexus' efficacy profile in multiple myeloma

BMS has put up the progression-free survival numbers on its recently-approved Zenbexus, more than doubling the score over a control cocktail of DVd.
Fraiser Kansteiner Oct 8, 2026 2:25pm
For biopharma manufacturing at speed and scale the future is flexible

For biopharma manufacturing at speed and scale, the future is flexible

Brought to you by Resilience
Tukysa

Pfizer's Tukysa approved as first-line maintenance therapy

Oct 8, 2026 11:25am
Advancing Treatment A Closer Look at ADT  Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
hand over keys buy house gift takeover acquisition

Viatris acquires Pacira for $1.65B

Oct 8, 2026 11:00am
Argenx

Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial

Oct 8, 2026 10:44am
More News

CSL Seqirus blasted for ‘multiple and prolonged deficiencies’

Oct 8, 2026 10:37am

Theramex and Asieris strike deal for drug-device combo Cevira

Oct 8, 2026 9:00am

PhRMA pushes back on CMS' Part B MFN model in court

Oct 8, 2026 8:05am

Sanofi drafts NBA champ to spread COVID, Nuvaxovid awareness

Oct 7, 2026 2:40pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings